These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37197802)

  • 21. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-throughput screen targeting malaria transmission stages opens new avenues for drug development.
    Buchholz K; Burke TA; Williamson KC; Wiegand RC; Wirth DF; Marti M
    J Infect Dis; 2011 May; 203(10):1445-53. PubMed ID: 21502082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Molecular Targets and Strategies for Antimalarial Discovery.
    Aguiar AC; de Sousa LRF; Garcia CRS; Oliva G; Guido RVC
    Curr Med Chem; 2019; 26(23):4380-4402. PubMed ID: 28875841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MalDA, Accelerating Malaria Drug Discovery.
    Yang T; Ottilie S; Istvan ES; Godinez-Macias KP; Lukens AK; Baragaña B; Campo B; Walpole C; Niles JC; Chibale K; Dechering KJ; Llinás M; Lee MCS; Kato N; Wyllie S; McNamara CW; Gamo FJ; Burrows J; Fidock DA; Goldberg DE; Gilbert IH; Wirth DF; Winzeler EA;
    Trends Parasitol; 2021 Jun; 37(6):493-507. PubMed ID: 33648890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimalarial Drug Discovery: From Quinine to the Most Recent Promising Clinical Drug Candidates.
    Tisnerat C; Dassonville-Klimpt A; Gosselet F; Sonnet P
    Curr Med Chem; 2022; 29(19):3326-3365. PubMed ID: 34344287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug targets for resistant malaria: Historic to future perspectives.
    Kumar S; Bhardwaj TR; Prasad DN; Singh RK
    Biomed Pharmacother; 2018 Aug; 104():8-27. PubMed ID: 29758416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.
    Bowman JD; Merino EF; Brooks CF; Striepen B; Carlier PR; Cassera MB
    Antimicrob Agents Chemother; 2014; 58(2):811-9. PubMed ID: 24247137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimalarial drug discovery - the path towards eradication.
    Burrows JN; Burlot E; Campo B; Cherbuin S; Jeanneret S; Leroy D; Spangenberg T; Waterson D; Wells TN; Willis P
    Parasitology; 2014 Jan; 141(1):128-39. PubMed ID: 23863111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in malaria drug discovery.
    Biamonte MA; Wanner J; Le Roch KG
    Bioorg Med Chem Lett; 2013 May; 23(10):2829-43. PubMed ID: 23587422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria chemotherapy: recent advances in drug development.
    Gemma S; Travagli V; Savini L; Novellino E; Campiani G; Butini S
    Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):195-225. PubMed ID: 20738242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds.
    Lucantoni L; Silvestrini F; Signore M; Siciliano G; Eldering M; Dechering KJ; Avery VM; Alano P
    Sci Rep; 2015 Nov; 5():16414. PubMed ID: 26553647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.
    Duffy S; Sykes ML; Jones AJ; Shelper TB; Simpson M; Lang R; Poulsen SA; Sleebs BE; Avery VM
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current therapies and future possibilities for drug development against liver-stage malaria.
    Raphemot R; Posfai D; Derbyshire ER
    J Clin Invest; 2016 Jun; 126(6):2013-20. PubMed ID: 27249674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prioritization of Molecular Targets for Antimalarial Drug Discovery.
    Forte B; Ottilie S; Plater A; Campo B; Dechering KJ; Gamo FJ; Goldberg DE; Istvan ES; Lee M; Lukens AK; McNamara CW; Niles JC; Okombo J; Pasaje CFA; Siegel MG; Wirth D; Wyllie S; Fidock DA; Baragaña B; Winzeler EA; Gilbert IH
    ACS Infect Dis; 2021 Oct; 7(10):2764-2776. PubMed ID: 34523908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the biology component of the drug discovery strategy for malaria eradication.
    Leroy D; Campo B; Ding XC; Burrows JN; Cherbuin S
    Trends Parasitol; 2014 Oct; 30(10):478-90. PubMed ID: 25131411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication.
    Poonam ; Gupta Y; Gupta N; Singh S; Wu L; Chhikara BS; Rawat M; Rathi B
    Med Res Rev; 2018 Sep; 38(5):1511-1535. PubMed ID: 29372568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4.
    Ashton TD; Dans MG; Favuzza P; Ngo A; Lehane AM; Zhang X; Qiu D; Chandra Maity B; De N; Schindler KA; Yeo T; Park H; Uhlemann AC; Churchyard A; Baum J; Fidock DA; Jarman KE; Lowes KN; Baud D; Brand S; Jackson PF; Cowman AF; Sleebs BE
    J Med Chem; 2023 Mar; 66(5):3540-3565. PubMed ID: 36812492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advances in the Development of Chemotherapeutic Agents for Malaria.
    Shrivastava N; Khan SA; Ahmad S; Al-Balushi K; Husain A
    Mini Rev Med Chem; 2021; 21(12):1487-1508. PubMed ID: 33349215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.